Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03735628
Title An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bayer
Indications

hepatocellular carcinoma

Advanced Solid Tumor

colorectal cancer

lung non-small cell carcinoma

head and neck squamous cell carcinoma

Therapies

Copanlisib + Nivolumab

Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Tower Hematology/Oncology Medical Group Beverly Hills California 90211-1850 United States Details
Sarcoma Oncology Center Santa Monica California 90403 United States Details
Rocky Mountain Cancer Centers Denver Colorado 80218 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
Rhode Island Hospital Providence Rhode Island 02903-4900 United States Details
Princess Margaret Cancer Centre Toronto Ontario M5G 1Z5 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field